| First Posted | New Trial Filing | Phase | Status |
|---|---|---|---|
| 2026-08-07 | NCT07753590 A Clinical Study to Evaluate Single-agent Therapy of BR113 for Injection in Patients With… | Phase 1 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT04514419 | Treatment of Breast Cancer With Trastuzumab + HS627/ Pertuzumab + Docetaxel | Breast Cancer | Active, Not Recruiting |
| Phase 2 | |||
| NCT06642909 | A Phase II Study of Zuberitamab Injection in Patients With Primary Membranous Nephropathy | Primary Membranous Nephropathy | Active, Not Recruiting |
| NCT07311538 | Phase IIa Study of BRY812 Monotherapy in Advanced Gynecological Malignancies | Advanced Gynecological Malignancies | Not Yet Recruiting |
| NCT07498647 | Clinical Trial of BR2251 Tablets for Patients With Primary Gout and Hyperuricemia | Gout and Hyperuricemia | Not Yet Recruiting |
| Phase 1 | |||
| NCT06937957 | A Study of BR111 in Patients With Advanced Malignancies | Advanced Malignancies | Recruiting |
| NCT06038058 | A Study of BRY812 for Injection Alone in Subjects With Advanced Malignancies | Advanced Malignancies | Recruiting |
| NCT07753590 | A Clinical Study to Evaluate Single-agent Therapy of BR113 for Injection in Patients With… | Advanced Solid Tumors | Not Yet Recruiting |